Floatz logo

VITAMIN D

Respiration Disorders

Columbia UniversitymixturePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Respiration Disorders cohort.

Asset / SponsorPhaseRating
PROPOFOL
FDA Office of Orphan Products Development
N/AD
FENTANYL
FDA Office of Orphan Products Development
N/AD
MIDAZOLAM
FDA Office of Orphan Products Development
N/AD

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →